Press release
obal Organ Transplant Immunosuppressant Drugs Market to Shrink to US$3.2 bn by 2023
Despite recent advances in medical science, post-operative complications are still a major challenge that the global organ replacement immunosuppressant drugs market needs to address. The long-standing inadequate medical coverage for immunosuppressant drugs can compromise the quality of care offered to patients suffering from organ failure. According to Transparency Market Research (TMR), this factor will translate into negative growth for the global organ transplant immunosuppressant drugs market from 2015 to 2023.
Download exclusive Sample of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1967
Besides this, the high cost of organ transplantation and the advent of stem cell therapies are limiting the market’s trajectory. The global organ transplant immunosuppressant market stood at US$5.1 bn in 2014. Exhibiting a CAGR of -5.0% between 2015 and 2023, the market’s valuation is expected to reach US$3.2 bn by the end of 2023.
Use of Immunosuppressant Drugs during Kidney Transplantation to Significantly Increase
Based on transplant, the demand for immunosuppressant drugs used during kidney transplantation was the highest in 2014. In the last couple of years, kidney transplantation has emerged as the most preferred treatment method for end-stage renal diseases. It has proven more cost-effective than prolonged periods of dialysis. Hence, TMR projects the demand for kidney replacement procedures to rise at a considerable pace during the forecast period. This will in turn will boost demand for immunosuppressant drugs from the segment, which held over 53.4% of the market in 2014. The kidney transplant segment is expected to maintain its dominance in the market through the forecast period.
Furthermore, the market is expected to witness demand from the bone marrow transplant segment as novel immunosuppressant drugs are developed for the treatment of graft-versus-host diseases. The use of these drugs is also expected to increase during liver, heart, and lung transplants.
View exclusive Global strategic Business report :
http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html
Robust Healthcare Infrastructure Fuels Demand for Immunosuppressant Drugs from North America
Regionally, North America led the global organ immunosuppressant drugs market with a share of 46.2% in 2014. The region exhibits high demand for immunosuppressant drugs due to the higher number of organ transplantations conducted therein. According to TMR, North America is expected to report the fastest growth due to the increasing number of successful organ replacement surgeries conducted in the region. This will in turn bolster demand for advanced immunosuppressant therapeutics.
Europe emerged as the second largest market for immunosuppressant drugs in the same year. These two regions will continue to lead the global market due to the recent improvements in surgical techniques, technology, and immunosuppressant drug discovery. The robust healthcare infrastructure in North America and Europe will seal the dominance of these regions in the global market.
Novartis AG, Astellas Pharma, Inc., F. Hoffmann-La Roche Ltd., Pfizer, Inc., and Sanofi are some of the most prominent companies operating in the market.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release obal Organ Transplant Immunosuppressant Drugs Market to Shrink to US$3.2 bn by 2023 here
News-ID: 394566 • Views: …
More Releases from TMR – Research Reports
Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home…
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture.
Another factor catalyzing growth in the global…
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.…
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units.
While expanding operations across emerging nations has…
More Releases for Immunosuppressant
Rising Demand For Organ Transplantation Drives Growth In The Immunosuppressant D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Organ Transplant Immunosuppressant Drugs Market Size By 2025?
In the past few years, the market for organ transplant immunosuppressant drugs has been experiencing consistent growth. The projection shows it will expand from $5.35 billion in 2024 to $5.47 billion in 2025, achieving a compound annual…
Rising Demand For Organ Transplantation Drives Growth In The Immunosuppressant D …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Organ Transplant Immunosuppressant Drugs Market Through 2025?
Over the years, there has been consistent growth in the size of the organ transplant immunosuppressant drugs market. It is projected to expand from a value of $5.35 billion in 2024 to $5.52 billion in…
Organ Transplant Immunosuppressant Drugs Market 2024-2033
The Business Research Company recently released a comprehensive report on the Global Organ Transplant Immunosuppressant Drugs Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The organ transplant…
Solid Organ Transplant Immunosuppressant Market 2021 | Detailed Report
The Solid Organ Transplant Immunosuppressant research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and…
Organ Transplant Immunosuppressant Market 2021 | Detailed Report
The Organ Transplant Immunosuppressant research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Organ Transplant Immunosuppressant research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force.
Get Free Sample PDF…
Global Immunosuppressant Drugs Market 2019 - Pharmacyclics, Inc., Janssen Biotec …
The Global Immunosuppressant Drugs Market 2019 - overview combining the data integration and analysis capabilities with the relevant findings, the report has predicted strong future growth of the market. The research analyst combining secondary research which involves reference to various statistical databases, relevant patent and regulatory databases and a number of internal a nd external proprietary databases. Cell Line Development Equipment report has focused on each region market…
